Hebei Weimiao Biology Co., LTD 1
Location
  • 100% safe delivery SGT-151 SGT-163 SGT-78 with best price

Jan . 09, 2025 13:54 Back to list

100% safe delivery SGT-151 SGT-163 SGT-78 with best price



Pregabalin, recognized globally for its CAS number 148553-50-8, stands as a prominent therapeutic agent in managing a range of neurological conditions. This compound, structurally related to the neurotransmitter gamma-aminobutyric acid (GABA), is often prescribed for its efficacy in treating nerve-related pain and as an anticonvulsant.

cas 148553-50-8 pregabalin

Designed with a specific mechanism of action, pregabalin modulates calcium channel activity in nerve cells. By binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, it decreases the release of several neurotransmitters, including glutamate, norepinephrine, and substance P. This action results in its effectiveness in alleviating symptoms of neuropathic pain, which can arise from conditions such as diabetes, shingles, spinal cord injuries, and fibromyalgia. From a clinical perspective, pregabalin offers significant relief for individuals suffering from generalized anxiety disorder (GAD) and as an adjunctive therapy for partial-onset seizures in adults. The therapeutic benefits are well-documented, supported by numerous studies and patient testimonials that underscore its role in improving the quality of life for patients experiencing severe anxiety or chronic pain.

cas 148553-50-8 pregabalin

Pregabalin's tolerability and safety profile make it an attractive option for long-term therapy. Patients report fewer adverse effects compared to older anticonvulsants and analgesics, with common side effects including dizziness, somnolence, dry mouth, and slight weight gain, which are generally manageable within the prescribed therapeutic ranges.cas 148553-50-8 pregabalin
As an authoritative option in its class, pregabalin's regulatory approval spans across more than 100 countries, signifying trust from medical professionals worldwide. Pharmacists and healthcare providers are readily available to furnish guidance on appropriate dosing regimens, which typically commence at lower doses with titration based on individual response and tolerability. Significant emphasis is placed on the trustworthiness of pregabalin, underscored by a robust body of evidence supporting its use. Its development included rigorous testing phases, and ongoing post-market surveillance continues to uphold its safety standards. This dedication to patient safety and therapeutic effectiveness solidifies its status as a preferred choice amongst prescribers when addressing neuropathic pain and other approved indications. The expertise surrounding pregabalin is also reflected in the abundant research dedicated to exploring its potential across new therapeutic areas. Researchers are investigating its efficacy in treating conditions such as migraine prophylaxis and restless leg syndrome, promising further expansion of its clinical applications. In conclusion, pregabalin, identified as CAS 148553-50-8, stands as a cornerstone in the management of neurological disorders, backed by extensive clinical experience and a solid foundation of scientific inquiry. Its distinct mechanism of action, coupled with a proven safety profile, ensures its status as a reliable, authoritative, and trusted therapeutic agent—a reputation upheld and validated through years of successful patient outcomes and clinical endorsements.
Share

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


sdSindhi